Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Zevalin and high-dose BEAM chemotherapy in non-Hodgkin's lymphoma

Dec. 19, 2002

Antitumor effects of CI-1033 in human breast cancer cells

Dec. 18, 2002

GW-572016 effective in model of tamoxifen-resistant breast cancer

Dec. 18, 2002

Targeting the uPA system with antibodies as a new approach to cancer therapy

Dec. 18, 2002

Cell-permeable MOE RNA oligonucleotide with telomerase-inhibitory effects

Dec. 18, 2002

OGX-011 enters clinical testing

Dec. 18, 2002

Oral formulation of Triapine demonstrates oral bioavailability

Dec. 18, 2002

Antitumor compounds discovered at Zenyaku Kogyo

Dec. 18, 2002

Small-molecule XIAP antagonist identified by La Jolla-based team

Dec. 17, 2002

Spectrum expands Neoquin study in superficial bladder cancer

Dec. 17, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.